Evaluating the efficacy of allopurinol for the treatment of cutaneous leishmaniasis

A. D’Oliveira,P. Machado,E. Carvalho
DOI: https://doi.org/10.1046/j.1365-4362.1997.00308.x
1997-12-01
International Journal of Dermatology
Abstract:This study was performed in Corte de Pedra, an area of L. braziliensis braziliensis transmission located 240 km southeast of Salvador, the capital of the state of Bahia in Brazil. This open controlled trial included 34 patients, aged 12 to 45 years, with leishmania‐positive skin test and a maximum of three ulcerated lesions (with a minimum lesion diameter of 10 mm and a maximum diameter of 50 mm) who had received no previous treatment. Exclusion criteria included chronic disease, use of other drugs, history of allergy to allopurinol, pregnancy, breast feeding, or forms of leishmaniasis other than cutaneous. Informed consent was obtained from all subjects after the nature of the procedures had been fully explained to them.
What problem does this paper attempt to address?